Experiment 67002

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationHUDE,GR: SZARKA,CE: ADAMS,A: RANGANATHAN,S: MC CAULEY,RA: WEINER,LM: LANGER,CJ: LITWIN,S: YESLOW,G: HALBERR,T: QIAN,MX: GALLO,JM:. (2000). PHASE I PHARMACOKINETIC TRIAL OF PERILLYL ALCOHOL (NSC 641066) IN PATIENTS WITH REFRACTORY SOLID MALIGNANCIES.. 6(8)
Amount utilized
Compound isolated
DiseaseVS.PRIMARY SITE OF CANCER: COLON, RENAL, LUNG, PAROTID, AGE RANGE: 43-70 YEARS; PATIENTS NUMBER: 17; DOSES RANGE: 1600-2800 MG/SQ M.
Dose amountVAR MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES